vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $18.9M, roughly 1.0× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -19.7%, a 34.3% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 16.3%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $2.4M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 16.7%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.

CURI vs ELMD — Head-to-Head

Bigger by revenue
CURI
CURI
1.0× larger
CURI
$19.2M
$18.9M
ELMD
Growing faster (revenue YoY)
CURI
CURI
+19.6% gap
CURI
35.8%
16.3%
ELMD
Higher net margin
ELMD
ELMD
34.3% more per $
ELMD
14.6%
-19.7%
CURI
More free cash flow
CURI
CURI
$1.6M more FCF
CURI
$3.9M
$2.4M
ELMD
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
16.7%
ELMD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CURI
CURI
ELMD
ELMD
Revenue
$19.2M
$18.9M
Net Profit
$-3.8M
$2.8M
Gross Margin
78.4%
Operating Margin
-17.6%
19.2%
Net Margin
-19.7%
14.6%
Revenue YoY
35.8%
16.3%
Net Profit YoY
-34.6%
40.3%
EPS (diluted)
$-0.07
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
ELMD
ELMD
Q4 25
$19.2M
$18.9M
Q3 25
$18.4M
$16.9M
Q2 25
$19.0M
$17.4M
Q1 25
$15.1M
$15.7M
Q4 24
$14.1M
$16.3M
Q3 24
$12.6M
$14.7M
Q2 24
$12.4M
$14.8M
Q1 24
$12.0M
$13.9M
Net Profit
CURI
CURI
ELMD
ELMD
Q4 25
$-3.8M
$2.8M
Q3 25
$-3.7M
$2.1M
Q2 25
$784.0K
$2.2M
Q1 25
$319.0K
$1.9M
Q4 24
$-2.8M
$2.0M
Q3 24
$-3.1M
$1.5M
Q2 24
$-2.0M
$1.8M
Q1 24
$-5.0M
$1.5M
Gross Margin
CURI
CURI
ELMD
ELMD
Q4 25
78.4%
Q3 25
78.1%
Q2 25
78.3%
Q1 25
78.0%
Q4 24
77.7%
Q3 24
78.3%
Q2 24
76.2%
Q1 24
74.8%
Operating Margin
CURI
CURI
ELMD
ELMD
Q4 25
-17.6%
19.2%
Q3 25
-24.5%
15.8%
Q2 25
2.5%
17.5%
Q1 25
0.5%
13.6%
Q4 24
-27.4%
15.6%
Q3 24
-25.8%
13.2%
Q2 24
-20.6%
15.7%
Q1 24
-30.4%
13.3%
Net Margin
CURI
CURI
ELMD
ELMD
Q4 25
-19.7%
14.6%
Q3 25
-20.4%
12.6%
Q2 25
4.1%
12.7%
Q1 25
2.1%
12.1%
Q4 24
-19.9%
12.1%
Q3 24
-24.3%
10.0%
Q2 24
-16.4%
12.3%
Q1 24
-42.0%
10.8%
EPS (diluted)
CURI
CURI
ELMD
ELMD
Q4 25
$-0.07
$0.32
Q3 25
$-0.06
$0.25
Q2 25
$0.01
$0.26
Q1 25
$0.01
$0.21
Q4 24
$-0.05
$0.22
Q3 24
$-0.06
$0.16
Q2 24
$-0.04
$0.20
Q1 24
$-0.09
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
ELMD
ELMD
Cash + ST InvestmentsLiquidity on hand
$27.3M
$13.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$45.4M
Total Assets
$75.7M
$54.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
ELMD
ELMD
Q4 25
$27.3M
$13.8M
Q3 25
$27.8M
$14.1M
Q2 25
$28.1M
$15.3M
Q1 25
$33.4M
$15.2M
Q4 24
$32.1M
$16.2M
Q3 24
$33.2M
$13.9M
Q2 24
$39.5M
$16.1M
Q1 24
$38.8M
$11.7M
Stockholders' Equity
CURI
CURI
ELMD
ELMD
Q4 25
$41.5M
$45.4M
Q3 25
$47.2M
$44.7M
Q2 25
$49.8M
$43.2M
Q1 25
$58.1M
$43.9M
Q4 24
$57.8M
$43.6M
Q3 24
$62.2M
$41.5M
Q2 24
$64.8M
$44.5M
Q1 24
$67.0M
$42.5M
Total Assets
CURI
CURI
ELMD
ELMD
Q4 25
$75.7M
$54.9M
Q3 25
$74.7M
$53.6M
Q2 25
$78.7M
$53.8M
Q1 25
$85.3M
$52.5M
Q4 24
$86.2M
$52.3M
Q3 24
$87.6M
$48.9M
Q2 24
$90.9M
$52.2M
Q1 24
$94.6M
$48.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
ELMD
ELMD
Operating Cash FlowLast quarter
$4.0M
$3.0M
Free Cash FlowOCF − Capex
$3.9M
$2.4M
FCF MarginFCF / Revenue
20.5%
12.7%
Capex IntensityCapex / Revenue
0.1%
3.4%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$7.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
ELMD
ELMD
Q4 25
$4.0M
$3.0M
Q3 25
$4.4M
$169.0K
Q2 25
$2.8M
$3.9M
Q1 25
$1.9M
$2.1M
Q4 24
$3.0M
$3.2M
Q3 24
$2.3M
$2.3M
Q2 24
$2.2M
$4.5M
Q1 24
$666.0K
$1.4M
Free Cash Flow
CURI
CURI
ELMD
ELMD
Q4 25
$3.9M
$2.4M
Q3 25
$-83.0K
Q2 25
$3.7M
Q1 25
$1.8M
$1.9M
Q4 24
$2.9M
Q3 24
$2.3M
Q2 24
$4.5M
Q1 24
$1.3M
FCF Margin
CURI
CURI
ELMD
ELMD
Q4 25
20.5%
12.7%
Q3 25
-0.5%
Q2 25
21.4%
Q1 25
12.2%
12.2%
Q4 24
18.0%
Q3 24
15.5%
Q2 24
30.1%
Q1 24
9.1%
Capex Intensity
CURI
CURI
ELMD
ELMD
Q4 25
0.1%
3.4%
Q3 25
0.0%
1.5%
Q2 25
0.0%
0.8%
Q1 25
0.5%
1.0%
Q4 24
0.0%
1.4%
Q3 24
0.0%
0.3%
Q2 24
0.0%
0.1%
Q1 24
0.0%
0.6%
Cash Conversion
CURI
CURI
ELMD
ELMD
Q4 25
1.10×
Q3 25
0.08×
Q2 25
3.56×
1.75×
Q1 25
6.03×
1.10×
Q4 24
1.60×
Q3 24
1.57×
Q2 24
2.46×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

ELMD
ELMD

Homecare$17.3M91%
Other$1.6M9%

Related Comparisons